Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (-Reference-Cited by-同舟云学术

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (

Published:2021-08 Issue: Volume:Volume 8 Page:937-949
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Chang Wei-Chou^ORCID,Hsu Hsian-He,Chiu Sung-Hua^ORCID,Huang Wen-Yen,Lo Cheng-Hsiang,Lin Hsuan-Hwai,Huang Pei-Ching,Shih Yu-Lueng,Wan Yung-Liang^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference52 articles.

1. Chemoembolization in Patients with Hepatocellular Carcinoma

2. Survival, Efficacy, and Safety of Small Versus Large Doxorubicin Drug-Eluting Beads TACE Chemoembolization in Patients With Unresectable HCC

3. Safety and Efficacy of Drug-eluting Bead Chemoembolization for Hepatocellular Carcinoma: Comparison of Small-versus Medium-size Particles

4. The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment

5. Transarterial Hepatic Chemoembolization with 70–150 µm Drug-Eluting Beads: Assessment of Clinical Safety and Liver Toxicity Profile

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma;Frontiers in Pharmacology;2024-08-05

2. Radiofrequency induced UCST-type gel-sol transition of metformin-conjugated nanogels for precisely synergizing thermal ablation and blood-vessel embolization;Chemical Engineering Journal;2024-07

3. Comparison of Small-Sized (70–150 μm) and Intermediate-Sized (100–300 μm) Drug-Eluting Embolics for Transarterial Chemoembolization of Small Hepatocellular Carcinomas (≤3 cm);Journal of Vascular and Interventional Radiology;2024-07

4. Transarterial chemoembolization using drug-eluting beads versus lipiodol in the treatment of unresectable hepatocellular carcinoma: propensity score matching;Journal of Gastrointestinal Oncology;2024-06

5. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-04